title: Serum soluble human leucocyte antigen class I in paediatric liver transplantation with live, related donors.
abstract: Serum soluble human leucocyte antigen (HLA) class-I is a useful marker for predicting immunological events in organ transplantation. In cadaver liver transplant cases it is especially the case that high amounts of soluble HLA-I are excreted from the grafts. In Japan, almost all liver transplants have been performed from living parent donors to their children. Therefore, it is interesting to know how soluble HLA-I changes in relation to clinical course. As part of this study we first examined serum concentrations of soluble HLA-I in 33 paediatric patients using enzyme-linked immunosorbent assay. Soluble HLA-I is composed of three different sized molecules (45, 39 and 34-36 kDa); then the change of distribution of these three molecules was demonstrated by Western blot analysis. When donor and recipient have different soluble HLA-I band patterns, the origin of the antigen can be assumed by this method. We found that in a comparison between pre- and post-transplants, the six out of eight (75%) patients that suffered episodes of acute rejection showed a significant elevation of soluble HLA-I, and all patients with infectious episodes had an elevated soluble HLA-I. Meanwhile, 10 out of 22 (45%) patients without any clinical complications still showed increased soluble HLA-I. The Western blot analysis showed that the soluble HLA-I molecules were considerably derived from the grafted liver, from one week to 24 months after grafting. In acute rejection, the band signals of donor origin were significantly increased. These signals were attenuated after immunosuppressive therapy. The grafted liver appears to contribute to the increase of soluble HLA-I following liver transplantation, and this increase is greater with the effects of the host immune system.
authors.affiliation: Department of Transplantation Immunology, Tokai University School of Medicine, Kyoto, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Hagihara
authors.forename: B
authors.initials: B
authors.lastname: Munkhbat
authors.forename: N
authors.initials: N
authors.lastname: Kanai
authors.forename: T
authors.initials: T
authors.lastname: Shimura
authors.forename: T
authors.initials: T
authors.lastname: Kiuchi
authors.forename: Y
authors.initials: Y
authors.lastname: Inomata
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: K
authors.initials: K
authors.lastname: Tsuji
mesh_terms: D000293:Adolescent; D015153:Blotting, Western; D002648:Child; D002675:Child, Preschool; D005260:Female; D015395:Histocompatibility Antigens Class I / Q000097:blood* / Q000502:physiology; D006801:Humans; D007223:Infant; D008099:Liver / Q000378:metabolism; D016031:Liver Transplantation / Q000502:physiology*; D008297:Male; D012995:Solubility; D014019:Tissue Donors
chemical_list: D015395:Histocompatibility Antigens Class I